Hep G2 CellsToxicity TestsCarcinoma, HepatocellularLiver NeoplasmsToxicity Tests, AcuteHempaTumor Cells, CulturedLiverDose-Response Relationship, DrugPropyl GallateCell LineEmeticsLethal Dose 50Plasminogen InactivatorsAntineoplastic Combined Chemotherapy ProtocolsToxicity Tests, ChronicDrug Administration ScheduleHydroxymethylglutaryl-CoA-Reductases, NADP-dependentLovastatinAntineoplastic AgentsApolipoprotein A-IRNA, MessengerArtificial OrgansHepatoblastomaCell SurvivalLiver Neoplasms, ExperimentalAsialoglycoprotein ReceptorOrganosilicon CompoundsTreatment OutcomeAntineoplastic Agents, PhytogenicCarboxypeptidase HReceptors, LDLKineticsOxaloacetic AcidMoraceaeLipoproteins, LDLOleic AcidCytochrome P-450 CYP2E1CisplatinApolipoproteins ACholesterolTime FactorsInfusions, IntravenousNo-Observed-Adverse-Effect LevelFluorouracilHydroxycholesterolsApolipoproteins BPrimaquineMevalonic AcidMaximum Tolerated DoseHydroxymethylglutaryl CoA ReductasesGlutathionePhenylenediaminesNeoplasmsAdministration, OralDoxorubicinCells, CulturedCell Line, TumorImmunosorbent TechniquesTransfectionCombined Modality TherapyOleic AcidsLipoproteins, HDLMolecular Sequence DataToxicologyCycloheximideAsialoglycoproteinsDeoxycytidineDrug EvaluationLeukopeniaDrug-Related Side Effects and Adverse ReactionsAlbuminsAntimetabolites, AntineoplasticL-Lactate DehydrogenaseRadiation InjuriesImmunoelectrophoresis, Two-DimensionalAntioxidantsPaclitaxelDrug-Induced Liver InjuryBase SequenceBiological TransportTranscription, GeneticApoptosisGene Expression RegulationNeutropeniaRecombinant ProteinsBlotting, NorthernToxicity Tests, SubchronicTunicamycinAntidotesSurvival AnalysisCamptothecinVitamin KCyclophosphamideApolipoprotein A-IIDisease-Free SurvivalRadiotherapy DosageChenodeoxycholic AcidDNAPromoter Regions, Genetic